glp-1 obesity drugs updates today Agonists Weight Loss Market Report, 2025-2030 Use of diabetes and anti-obesity

[PubMed] [Google Scholar] 106.Goncharova N.D., Vengerin A.A., Khavinson V.K., Lapin B.A

Semaglutide injections promote weight loss and metabolic repair by activating the GLP-1 receptor, which: Slows gastric emptying and digestion Reduces appetite and increases feelings of fullness Improves insulin response and blood sugar control Supports fat metabolism and energy efficiency Together, these effects help the body maintain balanced blood sugar levels and long-term weight control

Do you take any of these

This study was published in the Endocrine Journal in 2021

- Do not extract changes, differences, gains, losses, or percentages of change in these metrics

galement disponible en franais SOURCE Health Canada (HC) Media Enquiries: Health Canada, (613) 957-2983, [email protected]